Tempus AI (TEM): The “TechBio” Disruptor Cleaning Up Healthcare’s Data Mess

Tempus AI is attempting to solve healthcare’s massive data fragmentation problem by building one of the world’s largest proprietary clinical datasets through genomic testing and AI applications. While the company is seeing explosive 85% revenue growth, investors must weigh this potential against significant cash burn and a heavy debt load.